X-ray | GenomeWeb

X-ray

In Print

Premium

Microarray-Related Papers of Note Published in March 2009

The deal calls for Proteros to use its crystallography platform to decipher the X-ray structure of Axikin's protein, develop assays, identify active fragments, and develop the selected fragments into novel lead drug candidates.

Though the firm's revenues were down year over year for the quarter, its full-year 2008 revenues increased 7 percent. Investors also sent Bruker's shares up in early trade, as the firm handily beat analysts' consensus estimate for EPS.

Industry Briefs

Premium

Mosaiques, Bruker, Kinaxo, Xencor, CSL, Hybrigenics, Adlyfe, Wyeth

Receipts for the firm’s life sciences division, which houses its LC-MS tools, slid 1 percent but company officials said that LC-MS and mass-spec sales experienced double-digit growth.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.